These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 2488871)
1. Immunological modulation of dermal fibroblasts in scleroderma. Perlish JS; Fleischmajer R Immunol Ser; 1989; 46():605-24. PubMed ID: 2488871 [TBL] [Abstract][Full Text] [Related]
2. Connective tissue metabolism including cytokines in scleroderma. Smith EA Curr Opin Rheumatol; 1992 Dec; 4(6):869-77. PubMed ID: 1457283 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts. Chizzolini C; Rezzonico R; Ribbens C; Burger D; Wollheim FA; Dayer JM Arthritis Rheum; 1998 Nov; 41(11):2039-47. PubMed ID: 9811060 [TBL] [Abstract][Full Text] [Related]
4. Monocyte chemoattractant protein 1 released from glycosaminoglycans mediates its profibrotic effects in systemic sclerosis via the release of interleukin-4 from T cells. Distler JH; Jüngel A; Caretto D; Schulze-Horsel U; Kowal-Bielecka O; Gay RE; Michel BA; Müller-Ladner U; Kalden JR; Gay S; Distler O Arthritis Rheum; 2006 Jan; 54(1):214-25. PubMed ID: 16385517 [TBL] [Abstract][Full Text] [Related]
5. Products of activated mononuclear cells modulate accumulation of collagen by normal dermal and scleroderma fibroblasts in culture. Whiteside TL; Buckingham RB; Prince RK; Rodnan GP J Lab Clin Med; 1984 Sep; 104(3):355-69. PubMed ID: 6088655 [TBL] [Abstract][Full Text] [Related]
6. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha. Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479 [TBL] [Abstract][Full Text] [Related]
7. Effect of activated human mast cells and mast cell-derived mediators on proliferation, type I collagen production and glycosaminoglycans synthesis by human dermal fibroblasts. Abe M; Yokoyama Y; Amano H; Matsushima Y; Kan C; Ishikawa O Eur J Dermatol; 2002; 12(4):340-6. PubMed ID: 12095878 [TBL] [Abstract][Full Text] [Related]
8. Lymphokine/monokine inhibition of fibroblast proliferation and collagen production: role in progressive systemic sclerosis (PSS). Duncan MR; Perlish JS; Fleischmajer R J Invest Dermatol; 1984 Nov; 83(5):377-84. PubMed ID: 6333468 [TBL] [Abstract][Full Text] [Related]
9. Activation of dermal connective tissue in scleroderma. Kähäri VM Ann Med; 1993 Dec; 25(6):511-8. PubMed ID: 8292298 [TBL] [Abstract][Full Text] [Related]
10. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma. Pannu J; Gore-Hyer E; Yamanaka M; Smith EA; Rubinchik S; Dong JY; Jablonska S; Blaszczyk M; Trojanowska M Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427 [TBL] [Abstract][Full Text] [Related]
11. Update on pathophysiology of scleroderma with special reference to immunoinflammatory events. Chizzolini C Ann Med; 2007; 39(1):42-53. PubMed ID: 17364450 [TBL] [Abstract][Full Text] [Related]
12. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma. Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315 [TBL] [Abstract][Full Text] [Related]
13. Persistence of a reduced-collagen-producing phenotype in cultured scleroderma fibroblasts after short-term exposure to interferons. Duncan MR; Berman B J Clin Invest; 1987 May; 79(5):1318-24. PubMed ID: 2437154 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of the immunosuppressant FK-506 on human alpha2(I) collagen gene expression and transforming growth factor beta signaling in normal and scleroderma fibroblasts. Asano Y; Ihn H; Yamane K; Jinnin M; Mimura Y; Tamaki K Arthritis Rheum; 2005 Apr; 52(4):1237-47. PubMed ID: 15818662 [TBL] [Abstract][Full Text] [Related]
15. Increased expression of type I collagen induced by microfibril-associated glycoprotein 2: novel mechanistic insights into the molecular basis of dermal fibrosis in scleroderma. Lemaire R; Korn JH; Shipley JM; Lafyatis R Arthritis Rheum; 2005 Jun; 52(6):1812-23. PubMed ID: 15934076 [TBL] [Abstract][Full Text] [Related]
16. Spontaneous production of, and defective response to, interleukin-1 by peripheral blood mononuclear cells from patients with scleroderma. Alcocer-Varela J; Martinez-Cordero E; Alarcon-Segovia D Clin Exp Immunol; 1985 Mar; 59(3):666-72. PubMed ID: 3872755 [TBL] [Abstract][Full Text] [Related]
17. Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures. Potential role in fibrosis. Salmon-Ehr V; Serpier H; Nawrocki B; Gillery P; Clavel C; Kalis B; Birembaut P; Maquart FX Arch Dermatol; 1996 Jul; 132(7):802-6. PubMed ID: 8678573 [TBL] [Abstract][Full Text] [Related]
18. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model. Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379 [TBL] [Abstract][Full Text] [Related]
19. [Pathogenesis of systemic scleroderma: immunological aspects]. Mouthon L; García De La Peña-Lefebvre P; Chanseaud Y; Tamby MC; Boissier MC; Guillevin L Ann Med Interne (Paris); 2002 May; 153(3):167-78. PubMed ID: 12218899 [TBL] [Abstract][Full Text] [Related]
20. Interleukin 4 and prolonged hypoxia induce a higher gene expression of lysyl hydroxylase 2 and an altered cross-link pattern: important pathogenetic steps in early and late stage of systemic scleroderma? Brinckmann J; Kim S; Wu J; Reinhardt DP; Batmunkh C; Metzen E; Notbohm H; Bank RA; Krieg T; Hunzelmann N Matrix Biol; 2005 Oct; 24(7):459-68. PubMed ID: 16139999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]